An interlaboratory study of a candidate reference method for platelet counting

被引:0
作者
Harrison, P
Ault, KA
Chapman, S
Charie, L
Davis, B
Fujimoto, K
Houwen, B
Kunicka, K
Lacombe, F
Machin, S
Raynor, R
van Hove, L
van Assendelft, OW
机构
[1] UCL, London WC1E 6HX, England
[2] Maine Med Ctr, Res Inst, Portland, ME USA
[3] Bayer Diagnost, Tarrytown, NY USA
[4] Beckman Coulter, Miami, FL USA
[5] Sysmex, Kobe, Hyogo, Japan
[6] Loma Linda Univ, Loma Linda, CA 92350 USA
[7] ABX Diagnost, Pessac, France
[8] Abbott Labs, Santa Clara, CA USA
[9] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
platelets; counting; reference; RBC/platelet ratio;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A multinational interlaboratory task force explored the important variables of platelet reference counting and developed a candidate flow cytometric reference method based on the RBC/platelet ratio. A multicenter comparison was performed to determine whether the method met the necessary criteria and was precise enough to be recommended as a new reference method. Each laboratory analyzed serial dilutions of normal speciemens, stabilized material, and at least 60 patient specimens with a range of platelet counts from 1 to 400 X 10(3)/muL (1 -400 X 10(9)/L). Pooled analysis of the serial dilutions showed that RBC-platelet and RBC-RBC coincidence events became negligible at sufficiently high dilutions (ie, >1:1,000). All laboratories demonstrated excellent intra-assay and acceptable interlaboratory precision. Two antibodies (CD61 and CD41) were used for identifying platelets and individually gave acceptable results, but in a minority of samples, staining differences were observed. The optimum method thus uses a double-labeling procedure with a final dilution factor of 1:1,000. The study demonstrated that this method meets the criteria for a reference platelet count.
引用
收藏
页码:448 / 459
页数:12
相关论文
共 23 条
[1]   Trigger factors for prophylactic platelet transfusion [J].
Ancliff, PJ ;
Machin, SJ .
BLOOD REVIEWS, 1998, 12 (04) :234-238
[2]  
Ault K, 1996, LAB HEMATOL, V2, P265
[3]  
AULT KA, 1997, LAB HEMATOL, V3, P125
[4]  
BRECHER G, 1953, AM J CLIN PATHOL, V23, P15
[5]  
Davis B, 1999, LAB HEMATOL, V5, P15
[6]  
DICKERHOFF R, 1995, CLIN LAB HAEMATOL, V17, P163
[7]  
ENGLAND JM, 1988, WHO LAB, V88, P1
[8]   SAFETY OF STRINGENT PROPHYLACTIC PLATELET TRANSFUSION POLICY FOR PATIENTS WITH ACUTE-LEUKEMIA [J].
GMUR, J ;
BURGER, J ;
SCHANZ, U ;
FEHR, J ;
SCHAFFNER, A .
LANCET, 1991, 338 (8777) :1223-1226
[9]  
GRONER W, 1994, BLOOD, V84, pA687
[10]  
HAMMERSTROM H, 1992, CLIN LAB HAEMATOL, V14, P239